<DOC>
	<DOCNO>NCT00102128</DOCNO>
	<brief_summary>Study examine safety effectiveness implant skeletal muscle cell ( cell remove thigh muscle ) scar area heart muscle heart attack .</brief_summary>
	<brief_title>Study Examine Safety Effectiveness Implanted Skeletal Muscle Cells ( Cells Removed From Thigh Muscle ) Into Scarred Areas Heart Muscle After Heart Attack .</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Patients recommend coronary bypass surgery ( preferably cardiopulmonary support ) Ejection fraction ≥15 % ≤35 % Left ventricular myocardial infarction ( MI heart attack ) ≥4 week prior screen Need rapid surgical coronary revascularization Need relate cardiosurgical measure coronary surgery ( e.g . mitral valve repair valve replacement ) Patients leave ventricular aneurysm candidate leave ventricular aneurysmectomy leave ventricular reduction surgery ; patient receiving leave biventricular ( BiV ) pace therapy heart failure ( unless patient stabilize 6 month therapy ) Cardiomyopathy presume nonischemic origin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>